Drug Discovery & Development
Companies using AI, machine learning, or computational biology to discover new drug candidates, identify drug targets, predict drug efficacy, or accelerate pharmaceutical development. Includes both small molecule and biologics development, precision oncology drug discovery, and AI-driven target identification and molecule design.
Featured Companies
All Companies(64)
A2A Pharmaceuticals
AI-driven pharmaceutical company focused on discovering and developing novel drug candidates using computational biology and machine learning.
AbCellera
AbCellera uses AI and machine learning to discover and develop antibody-based therapeutics and vaccines.
Absci
Absci uses AI-powered computational biology and machine learning to accelerate drug discovery and optimize therapeutic proteins and antibodies.
Adaptyv Bio
Adaptyv Bio operates the world's fastest protein validation lab, providing automated experimental testing services for AI-designed proteins. The company enables protein engineers to validate binding, expression, and thermostability of novel protein designs through a fully automated platform with 3-week turnaround times.
Aitia
Aitia is a drug discovery and development company leveraging AI and computational biology to identify novel therapeutic targets and accelerate drug development.
Anagenex
Anagenex is a biotechnology company focused on drug discovery and development. The company appears to operate in the pharmaceutical research space, though specific details about their technology platform, therapeutic areas, and target markets are not available from the provided content.
Aqemia
Aqemia is a drug discovery company advancing next-generation medicines using generative AI and deep physics. The company combines AI-augmented discovery with computational chemistry to develop novel therapeutics at scale.
Arctoris
Arctoris is a Partnership Research Organisation (PRO) providing automated wet lab biology R&D and data generation services for biotech, techbio, and pharma companies through its Ulysses® robotic platform.
Aria Pharmaceuticals
Aria Pharmaceuticals appears to be a pharmaceutical company focused on drug discovery and development. Based on the limited information available, the company operates in the pharmaceutical sector.
Atomwise
Atomwise operates an AI superplatform that explores chemical space to discover novel, drug-like small molecules. The company focuses on developing first- and best-in-class therapeutics for immune and inflammatory diseases.
B Isomorphic
Isomorphic Labs is an AI-first drug discovery company building on the Nobel Prize-winning AlphaFold system. The company combines machine learning specialists with drug discovery experts to develop predictive and generative AI models that accelerate the design of novel therapeutics across multiple modalities.
BigHat Biosciences
BigHat Biosciences designs safer, more effective antibody therapies using machine learning and synthetic biology. The company's Milliner platform integrates high-speed wet lab characterization with AI to accelerate antibody discovery and engineering for challenging diseases.
BioAge
BioAge is a clinical-stage biopharmaceutical company developing therapeutic candidates for metabolic diseases by targeting the biology of human aging.
BioXcel Therapeutics
BioXcel Therapeutics is a clinical-stage biopharmaceutical company using artificial intelligence to identify and develop novel medicines in neuroscience and immuno-oncology. The company's lead product IGALMI® treats acute agitation.
Cambrium
Cambrium develops next-generation materials using AI and bioscience to design enzymes, polymers, and peptides at scale. The company partners with industries including apparel, personal care, mobility, and home care to create materials with unprecedented performance characteristics.
Cellarity
Cellarity is a biotechnology company developing Cell State-Correcting therapeutics for complex diseases. Using a multi-omics AI-powered platform, they map cellular interactions and regulate genetic switches to restore proper cell function.
Certara
Certara provides integrated software, services, and strategic expertise for pharmaceutical drug development. The company serves biotech, pharma, and CROs with biosimulation modeling, regulatory strategy, data standardization, and market access solutions across all development phases.
Chai Discovery
Chai Discovery builds frontier AI models to predict and reprogram molecular interactions for drug discovery. The company specializes in de novo antibody and protein design, enabling pharmaceutical companies to design drug-like therapeutics computationally with high success rates.
Charles River Laboratories
Charles River Laboratories uses Logica, an AI-powered drug development solution, to translate biological insights and accelerate pharmaceutical discovery and development.
Charm Therapeutics
CHARM Therapeutics is a drug discovery company developing next-generation menin inhibitors for Acute Myeloid Leukemia (AML). Their best-in-class approach aims to reprogram leukemic cells and address resistance observed with first-generation menin inhibitors.
Chemify
Chemify digitizes and automates chemical discovery and synthesis using Chemputation—a universal chemical programming language combined with advanced robotics and AI. The company translates digital code into real molecules, transforming how medicines and materials are discovered and manufactured.
Cradle
Cradle is an AI-powered protein design platform that helps biopharma and industrial biotech teams accelerate protein engineering. The platform enables scientists to generate and optimize protein candidates across multiple properties simultaneously, achieving 2-12x faster development timelines through machine learning models that learn from experimental data.
Cyclica
CYCLICA is an international marketplace for buying and selling used heavy equipment, construction machinery, engines, spare parts, and industrial equipment. The platform offers certified, inspected machinery with transparent specifications and global distribution services.
Diffuse Bio
Diffuse Bio builds generative AI systems to engineer novel protein therapeutics with unprecedented control and accuracy. The company enables rapid protein binder design and optimization, moving protein therapeutics from lab to laptop with AI-powered design tools.
Enveda Biosciences
Enveda Biosciences uses AI to decode nature's hidden chemistry for drug discovery. Their platform reads and translates molecules from the natural world at unprecedented speed and scale, making 99.9% of nature's chemistry accessible to drug hunters for the first time.
Evaxion Biotech
Evaxion Biotech is a TechBio company using its AI-Immunology™ platform to develop personalized cancer vaccines and next-generation vaccines for infectious diseases. The platform simulates the human immune system to identify and develop novel immunotherapies.
Exscientia
Recursion is a TechBio company using AI and one of the world's largest proprietary biological datasets to accelerate drug discovery. The company's Recursion OS platform combines phenomics, transcriptomics, proteomics, and patient data to identify novel drug targets and design optimized molecules for oncology and rare diseases.
Generate Biomedicines
Generate Biomedicines is a biotechnology company pioneering generative AI to design novel therapeutic proteins and biologics. The company uses machine learning to generate new protein structures and sequences for drug discovery and development.
Genesis Therapeutics
Genesis Therapeutics is an AI-powered drug discovery company developing novel therapeutics for severe disorders with high unmet medical need.
Healx
Healx is a biotechnology company using AI-powered drug discovery to develop treatments for rare diseases. The company combines machine learning with patient data to identify and repurpose existing drugs for rare disease populations.
Iambic Therapeutics
Iambic Therapeutics is an AI-driven drug discovery company that combines computational chemistry, machine learning, and experimental biology to design and develop novel small molecule therapeutics. The company focuses on creating precision medicines for complex diseases.
Iktos
Iktos leverages cutting-edge generative AI and robotics to transform drug discovery. The company integrates AI-driven molecular design (Makya), retrosynthesis planning (Spaya), and automated synthesis and testing through robotic labs to accelerate the development of new treatments.
Imvaria, Inc
IMVARIA is a software-as-medical-device (SaMD) company that develops AI-driven digital biomarker solutions to help clinicians make accurate diagnoses and prognoses at earlier stages of disease. The company focuses on reducing the need for invasive biopsy testing, starting with lung diseases including idiopathic pulmonary fibrosis and lung cancer.
insitro
Insitro is a data-driven drug discovery company leveraging machine learning and high-throughput biology to create AI therapeutics.
Labcorp Drug Development
Labcorp Drug Development provides AI-driven solutions and real-world data analytics for biopharma companies. The company leverages one of the world's largest diagnostic datasets (45B+ test results annually) to accelerate clinical trials, optimize patient recruitment, and generate regulatory-grade evidence across the drug development lifecycle.
LabGenius
LabGenius Therapeutics develops ML-driven antibody therapeutics for solid tumours using its EVA™ platform. The company combines automated discovery with machine learning to rapidly identify and optimise complex therapeutic antibodies, focusing on selectivity-enhanced treatments.
Lantern Pharma
Lantern Pharma is a clinical-stage oncology company leveraging artificial intelligence, machine learning, and genomics to accelerate cancer drug discovery and development. The company develops precision oncology therapies with reduced costs and timelines.
Menten AI
Menten AI develops generative AI technology for designing cyclic peptide therapeutics that target previously undruggable proteins. Their MAUD 1.0 platform combines physics-based modeling and quantum simulations to create peptide macrocycles with drug-like properties including oral bioavailability and cell permeability.
Nabla Bio
Nabla Bio combines generative AI with large-scale, human-relevant experimental systems to design biologics from scratch. Their JAM platform enables de novo antibody design, multispecifics development, and targeting of previously undruggable proteins for pharmaceutical partners.
Nimbus Therapeutics
Nimbus Therapeutics is a structure-based drug discovery company developing breakthrough small molecule medicines through AI-enhanced computational chemistry. The company pursues well-validated but difficult-to-drug targets with high potential to transform patients' lives, focusing on oncology, immunology, and metabolic diseases.
Notable Labs
Notable Labs is a precision oncology company that uses AI-driven functional precision medicine to match cancer patients with optimal therapies through ex vivo drug testing on patient tumor samples.
NuMedii
NuMedii is a biopharmaceutical company that uses artificial intelligence and systems biology to discover and develop precision therapeutics for complex diseases.
Owkin
Owkin is pioneering advanced AI to automate biopharmaceutical R&D. Their flagship product K Pro is an AI scientist that informs decision-making across drug discovery and development, trained on multimodal patient data from a global network of healthcare institutions.
Peptone
Peptone is a drug discovery and development company focused on leveraging AI and computational methods to accelerate the identification and optimization of therapeutic peptides and biologics.
Pharos iBio
Pharos iBio appears to be a company in the Drug Discovery & Development space. Based on the limited website content available, specific details about their products, services, and target markets could not be determined.
Polaris Quantum Biotech
PolarisQB applies quantum computing and quantum-inspired algorithms to drug discovery, enabling pharmaceutical and biotech companies to explore vastly larger chemical spaces than traditional methods. Their Quantum-Aided Drug Design (QuADD) platform identifies optimized lead molecules in days rather than months.
PostEra
PostEra is building a modern 21st century biopharma using Proton, their AI platform for medicinal chemistry, to accelerate the discovery of new medicines for patients. The company combines machine learning with drug discovery to develop small molecule programs through partnerships with major pharmaceutical companies.
Recursion Pharmaceuticals
Recursion Pharmaceuticals is a clinical-stage biotech company decoding biology by running millions of experiments and applying AI to accelerate drug discovery.
Relay Therapeutics
Relay Therapeutics is a precision medicine company that uses its proprietary Dynamo platform to visualize protein motion and drug previously intractable targets. The company focuses on developing therapeutic candidates for precision oncology and genetic diseases.
Simulations Plus
Simulations Plus provides modeling and simulation software and consulting services for pharmaceutical drug development. The company supports scientists from discovery through commercialization with PBPK, pharmacometrics, QSP/QST, and ADMET prediction tools.
Standigm
Standigm is an AI-driven drug discovery company that leverages deep learning and machine learning to identify novel drug candidates and therapeutic targets. The platform accelerates the discovery process for pharmaceutical companies and research institutions across multiple disease areas.
Syntekabio
Syntekabio is an AI-driven drug discovery company that accelerates pharmaceutical innovation through supercomputing power, big data, and proprietary AI platforms. The company specializes in small molecule, antibody, and cancer vaccine discovery for pharmaceutical and biotech partners.
Terray Therapeutics
Terray Therapeutics is an AI-native drug discovery company that combines proprietary ultra-dense microarray experimentation with custom AI models to discover small molecule therapeutics. The company has built the EMMI platform to navigate unexplored chemical space and tackle traditionally undruggable targets.
Therapanacea SAS
TheraPanacea is an award-winning medical technology company that develops AI-powered software for radiotherapy treatment planning. Their flagship product ART-Plan™ provides automated contouring, image fusion, and adaptive radiotherapy solutions for cancer centers worldwide.
Treeline Biosciences
Treeline Biosciences is a drug discovery and development company focused on developing novel therapeutics. The company operates in the pharmaceutical and biotechnology sector.
Turbine
Turbine operates a Virtual Lab platform that simulates biological experiments at scale for biopharma R&D. The company enables drug discovery teams to run millions of virtual experiments on oncology targets, ADCs, and combination therapies, accelerating preclinical decision-making and reducing wet lab costs.
Valence Discovery
Valence Labs (formerly Valence Discovery) is Recursion's AI research engine developing computational models to predict cellular responses to interventions. They leverage massive datasets, supercomputing power, and machine learning to build 'virtual cells' that accelerate drug discovery.
Valo Health
Valo Health applies AI and machine learning to accelerate drug discovery, optimize clinical trials, and improve population health outcomes.
Variational AI
Variational AI develops Enki™, a generative AI platform that designs novel, synthesis-ready small molecules for early-stage drug discovery. The platform generates optimized lead-like compounds tailored to target product profiles, enabling pharma and biotech partners to bypass traditional hit identification and move directly into lead optimization.
Verge Genomics
Verge Labs (formerly Verge Genomics) builds foundation models for precision neurology using proprietary multi-modal patient brain data. The company develops AI-discovered drugs and provides a platform for target discovery, biomarker identification, and patient stratification in neuroscience.
Vysioneer
Vysioneer uses artificial intelligence and cloud services to revolutionize cancer care and treatment optimization.
Xaira Therapeutics
AI-powered drug discovery platform leveraging machine learning to identify and develop novel therapeutics.
XtalPi
XtalPi is an AI drug discovery company leveraging artificial intelligence, quantum physics, and robotics to accelerate pharmaceutical research.
Related Articles
All News →
Why the FDA Is Betting on Biology-Driven AI to Fix Drug Development's $2 Billion Failure Problem
Mechanistic AI that explains *why* drugs work—rather than just predicting outcomes—could finally give regulators the transparency needed to accelerate drug development and reduce catastrophic trial failures.
What Healthcare AI Can Learn From Vertical AI in Construction
The health AI industry's most durable companies will be those that go deepest in a single clinical domain — not the ones that build the most general-purpose platform. The success of vertical AI in adjacent industries offers a clear template.
Recursion Pharmaceuticals Advances Three AI-Discovered Drug Candidates Into Phase 2 Trials
Recursion Pharmaceuticals has announced that three drug candidates identified through its AI-powered drug discovery platform have advanced into Phase 2 clinical trials, marking a significant milestone for the AI-native pharmaceutical development model.